News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fidia Farmaceutici, S.p.A. Release: Fidia Farmaceutici, S.p.A.'s European Patent on Cross-Linked Gel Slurries Has Been Entirely Revoked by the EPO Board of Appeal


12/2/2008 9:13:14 AM

ABANO TERME, Italy--(BUSINESS WIRE)--Fidia Farmaceutici S.p.A. announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation (Cambridge, MA, USA) has been entirely successful. Indeed, Genzyme's EP patent has been finally revoked in its entirety by the EPO Board of Appeal (decision T 0450/03 of 12 February 2008).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES